New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
Bryan A. Cotton, MD, MPH, discusses damage control resuscitation with new iCritical Care Podcast editor Jeffrey Guy, MD, MSc, MMHC.
Kyle B. Enfield, MD, and Sheila A. Alexander, BSN, PhD, RN, FCCM, review targeted temperature management, especially its use in treating intracerebral hemorrhage.
The ARREST Trial compared extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation to advanced cardiac life support (ACLS) treatment in patients with out-of-hospital cardiac arrest (OHCA). This month’s Concise Critical Appraisal takes a deep dive into the trial, published in The Lancet.
Is cardiopulmonary resuscitation (CPR) futile in hospitalized patients with COVID-19 experiencing cardiac arrest? A study recently published in Critical Care Medicine sought to answer this question and provide more data around outcomes of in-hospital cardiac arrest in patients with COVID-19.
Hernández et al (JAMA. 2019;321:654-664) set out to address that question with a multicenter randomized trial in which they compared two resuscitative targets: the normalization of blood lactate and the normalization of peripheral perfusion as quantified by capillary refill time.
Ruemmler et al (Resuscitation. 2018;132:56-62) set out to compare intermittent positive pressure ventilation to passive oxygenation (continuous positive airway pressure) and a novel ultra-low tidal volume ventilation (ULTVV) regimen.